Weight Management

GLP-1 RA side effects such as nausea and vomiting can be minimized by starting at the lowest available dose and titrating slowly; Dr Caroline Apovian explains why.

GLP-1 receptor agonist-based medications for obesity modify gut hormone imbalances, making diet and lifestyle change far more effective, explains Caroline Apovian, MD.

The American College of Physicians announced an initiative that renews and expands its focus on equitable access to obesity care, including new resources for physicians.

Dubbed the "twincretin," the GLP-1/GIP RA met weight and HgbA1c reduction endpoints, with nearly half of tirzepatide-treated patients achieving weight loss of at least 15%.

For persons diagnosed with obesity, a prescription antiobesity medication is just one part of optimal care that includes significant lifestyle change as well, says Caroline Apovian, MD.

Apovian: GLP-1 receptor agonists are the first antiobesity medications to simulate human physiology, which is why they sustain weight loss and are meant for long-term use.

Your daily dose of clinical news you may have missed.

Caroline Apovian, MD, highlights how drugs like semaglutide 2.4 mg treat the chronic relapsing disease of obesity and why a distinction from "weight-loss drugs" is critical.

Significant decreases were observed in bone strength and mean and trabecular BMD 12 months after sleeve gastrectomy in patients aged 13 to 25 years, a new study reveals.

Among other improvements, bariatric surgery may help reverse peripheral neuropathy and stabilize cardiovascular autonomic neuropathy, according to new findings.

Screening for diabetes by weight will increase diagnoses; weight regain after loss doesn't cancel health benefits; strategy tested to improve RSV detection; and 2 more studies of note.

The Mediterranean and low-fat dietary patterns were the only 2 out of 7 "structured, named" programs shown to reduce risk of mortality, CV events in persons at risk.

A new study examines the legacy effects of weight loss on cardiometabolic disease risk factors, finding benefits persist up to 5 years, despite weight regain.

Each of the quotes is taken from a study reviewed on Patient Care during the week and was chosen for the research team’s passion about the implications of their findings.

Ketogenic diet comes with cautions, new benefits of bempedoic acid, how to increase GDMT for type 2 diabetes, and CV consequences of cannabis lead findings from ACC 2023.

ACC2023. Risk for MACE was nearly 7-fold higher in participants on a keto diet whose LDL-C was already high compared with those on a standard diet with LDL-C in a normal range.

Nearly half of US adults aged 50 to 80 years report at least 1 symptom of addictive eating, a caution flag for primary care according to these experts.

ACC 2023. Results from a 2-decade study showed that all-cause mortality rates were significantly higher in patients with obesity with uncontrolled HTN compared to those without HTN.

Food addiction researcher Ashley Gearhardt, PhD, links survey data on addictive behavior in older adults to the dawn of aggressive food marketing.

Many older adults show symptoms of food addiction, a new survey found. Is it time to start screening? A primary care physician considers the feasibility and the value.

Behavioral problems with food were found more common among women in their 50s and 60s and among men and women who report being lonely, in poor health, and overweight.

Yale Food Addiction Scale author Ashley Gearhardt, PhD, and National Poll on Healthy Aging director Jeffrey Kullgren, MD, MS, MPH, highlight new survey findings.

Foods that are "engineered" with refined carbohydrates and fats that are rapidly absorbed can lead to cravings on par with those for alcohol and nicotine, says Ashley Gearhardt, PhD.

The 6 obesity care organizations are collaborating to overcome the roadblocks to effective and equitable treatment for the ubiquitous, chronic, and deadly disease.

A pivotal study with 40-year follow-up of post-bariatric surgery patients reinforces long-term benefits of the procedures on all-cause and cause-specific mortality.

Results from longitudinal prospective cohort study underscore the importance of monitoring patients’ weight throughout adulthood to reduce the risk of frailty.

Your daily dose of clinical news you may have missed.

Sustained weight loss with semaglutide 2.4 mg is a result of the drug's effects on control of eating, including reduced cravings and hunger and increased satiety, study authors write.

When counseling patients about weight gain prevention, limiting the frequency of larger meals is more beneficial than time-restricted eating, advised authors.

The 13 Key Action Steps in the AAP's landmark obesity guidelines reflect more than a decade of research on evaluation and treatment of the disease in children and adolescents.